No limit to Nioa’s ambition, now plans $50m gun factory

Australian owned defence contractor NIOA has revealed plans for a $50 million small arms and weapons factory, adding to the numerous new factories and expansions already underway by the Queensland group. The company said historical weapons manufacturing centres Lithgow in New South Wales and Benalla in Victoria as well as Brisbane are being considered as…

Ethical and sustainable supply chains – by Rob Stummer

Disruptions to global supply chains have put increasing pressure on the environment and on workers rights. Here Rob Stummer explains the threats and the ways that manufacturers can ensure their supply chains remain ethical and sustainable, despite pandemic pressures. There’s no doubt that the pandemic has put global supply chains under extraordinary pressure, with everyone…

IDT Australia misses out on federal mRNA support

While Canberra has announced an ‘in-principal’ agreement with US company Moderna to manufacture mRNA vaccines in Victoria, Melbourne pharmaceutical and vaccine manufacturer IDT Australia has announced it has been informed that it has missed out on government support. The company said today it was disappointed that its proposal to establish mRNA manufacturing in response to…

Hancock Prospecting to develop low carbon steel making technology

The University of Melbourne and Hancock Prospecting have entered into a multi-year partnership to develop their Carbelec technology that utilises electrolysis at low temperature to convert carbon dioxide (CO2) into reusable carbon and oxygen. Carbelec is seen as a potential game changer for industries such as steel making as it could enable the constant capture…

GMG tests its graphene aluminium-ion battery production

Graphene Manufacturing Group has fired up its pilot plant producing its graphene aluminium-ion batteries and has manufactured its first G+AI batteries in coin cell format. Additional equipment to enable the manufacture G+AI Batteries in pouch pack cell format has been ordered and is expected to arrive in early 2022, according to the Richlands, Queensland company.…

Biotech giant CSL in massive global takeover

Analysis by Peter Roberts Australia’s largest and most successful manufacturer, global blood products and vaccine powerhouse CSL, is to raise billions from investors to execute a $17.2 billion all cash takeover of a complementary healthcare business, Swiss pharmaceutical manufacturer Vifor. The massive takeover expands CSL’s global footprint into complementary areas including haematology, thrombosis, cardiovascular and…